Clinical Trial Update: Highly Suppressive Treg in Delayed and Slow Graft Function After Kidney Transplantation

View source ↗

Summary

A trial evaluating regulatory T cell therapy to mitigate delayed graft function after kidney transplantation is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delayed Graft Function

Drugs mentioned

• Highly Suppressive Treg (regulatory T cells)

Snippet

Sponsor: St. Louis University | Conditions: DGF, Kidney Transplant; Complications | Status: ACTIVE_NOT_RECRUITING